NURECA
Back to All Ratios
|
NURECA Last 5 Year Working Capital/Sales History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Working Capital/Sales(x) | 0.69 | 0.55 | 0.66 | 1.39 | 1.39 |
What is the latest Working Capital/Sales ratio of NURECA ?
| Year | Working Capital/Sales |
|---|---|
| Mar2025 | 0.69 |
| Mar2024 | 0.55 |
| Mar2023 | 0.66 |
| Mar2022 | 1.39 |
| Mar2021 | 1.39 |
How is Working Capital/Sales of NURECA Trending?
| Years | Working Capital/Sales | % Change | |
|---|---|---|---|
| Mar2025 | 0.69 | 25.45 | |
| Mar2024 | 0.55 | -16.67 | |
| Mar2023 | 0.66 | -52.52 | |
| Mar2022 | 1.39 | 0.00 | |
| Mar2021 | 1.39 | - | |
Other Financial Ratios of NURECA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Working Capital/Sales ratio of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹272.0 Cr | -4.2% | 17.6% | -8.1% | Stock Analytics | |
| POLY MEDICURE | ₹19,853.8 Cr | 3.5% | 5.1% | -28.9% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -4.2% |
17.6% |
-8.1% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses